Cover image of show The Lupus Forum

The Lupus Forum

Podcast door The Lupus Forum

Engels

Technologie en Wetenschap

Tijdelijke aanbieding

3 maanden voor € 1

Daarna € 9,99 / maandElk moment opzegbaar.

  • 20 uur luisterboeken / maand
  • Podcasts die je alleen op Podimo hoort
  • Gratis podcasts
Begin hier

Over The Lupus Forum

Welcome to the Lupus Forum. The Lupus Forum is an educational website developed under the auspices of the University of Leeds and is dedicated to the dissemination of the latest developments in the field of lupus. It provides continuing medical education to clinicians around the globe to facilitate greater understanding of lupus, its treatments, and clinical practice.

Alle afleveringen

84 afleveringen
episode Discussing Lupus: CM313 and predictors of damage in accrual in SLE artwork

Discussing Lupus: CM313 and predictors of damage in accrual in SLE

Professor Ed Vital discusses two key publications covered on the Lupus Forum in December. his podcast reviews data from a randomised, double-blind, placebo-controlled Phase Ib/IIa trial of the anti-CD38 monoclonal antibody CM313 in adults with systemic lupus erythematosus (SLE), focusing on safety, tolerability, pharmacokinetics, pharmacodynamics, immunogenicity, and preliminary efficacy. The episode also examines predictors of damage accrual by organ domain in SLE, highlighting factors associated with long-term disease outcomes. If you are interested in the papers discussed, head on over to the Lupus Forum today! Download our latest slide decks and stay up to date with our monthly podcasts, all through this free independent resource: https://lupus-forum.com/

24 dec 2025 - 21 min
episode Discussing Lupus: Belimumab and CD19 CAR NK-cell therapy in systemic lupus erythematosus artwork

Discussing Lupus: Belimumab and CD19 CAR NK-cell therapy in systemic lupus erythematosus

Professor Richard Furie and Doctor Guillermo J. Pons-Estel review two key publications covered on the Lupus Forum in November. This podcast reports data from a multicentre, randomised, double-blind, placebo-controlled trial evaluating low-dose belimumab in patients with systemic lupus erythematosus (SLE), with a focus on disease flare prevention. The episode also reports findings on the efficacy and safety of allogeneic CD19 CAR NK-cell therapy in SLE, based on a case series conducted in China in patients with mild disease activity. If you are interested in the papers discussed, head on over to the Lupus Forum today!

23 dec 2025 - 20 min
episode Discussing Lupus: Emerging treatments in SLE and LN artwork

Discussing Lupus: Emerging treatments in SLE and LN

Professor Vibeke Strand highlights the emerging treatments in SLE and LN. This podcast reports the efficacy and safety results of a Phase 3 trial of telitacicept at a dose of 160mg weekly as compared with PBO in Chinese persons with active SLE. The efficacy and safety of SC secukinumab 300mg compared with PBO, in combination with the SoC, in patients with active LN is also reported. If you are interested in the papers discussed, head on over to the Lupus Forum today! Download our latest slide decks and stay up to date with our monthly podcasts, all through this free independent resource: https://lupus-forum.com/

04 dec 2025 - 14 min
episode Early Use of Advanced Therapies in Lupus: Highlights Podcast artwork

Early Use of Advanced Therapies in Lupus: Highlights Podcast

Join Professor Ed Vital, Dr Guillermo J. Pons-Estel, Professor Richard Furie and Professor Chris Edwards on the Lupus Forum for their discussion of the recent webinar “Early use of advanced therapies in lupus”. Watch them discuss key highlights from the webinar, including limitations of SoC, insights from clinical trials and strategies for early intervention with advanced therapies. Visit www.lupusforum.com to access the full webinar content, including detailed slide materials from Dr Guillermo J. Pons-Estel, Professor Richard Furie and Professor Chris Edwards.

27 nov 2025 - 22 min
episode Lupus at ACR 2025: Review Podcast artwork

Lupus at ACR 2025: Review Podcast

Join Professors Ed Vital and Maria Dall'Era as they review their highlights of the recent ACR 2025 congress, watch them discuss their abstracts and highlight key information.

06 nov 2025 - 35 min
Super app. Onthoud waar je bent gebleven en wat je interesses zijn. Heel veel keuze!
Super app. Onthoud waar je bent gebleven en wat je interesses zijn. Heel veel keuze!
Makkelijk in gebruik!
App ziet er mooi uit, navigatie is even wennen maar overzichtelijk.

Kies je abonnement

Tijdelijke aanbieding

Premium

20 uur aan luisterboeken

  • Podcasts die je alleen op Podimo hoort

  • Gratis podcasts

  • Elk moment opzegbaar

3 maanden voor € 1
Daarna € 9,99 / maand

Begin hier

Premium Plus

Onbeperkt luisterboeken

  • Podcasts die je alleen op Podimo hoort

  • Gratis podcasts

  • Elk moment opzegbaar

Probeer 30 dagen gratis
Daarna € 11,99 / month

Probeer gratis

Alleen bij Podimo

Populaire luisterboeken

Begin hier

3 maanden voor € 1. Daarna € 9,99 / maand. Elk moment opzegbaar.